Functional genomic analysis of a RUNX3 polymorphism associated with ankylosing spondylitis

Objective To investigate the functional consequences of the single-nucleotide polymorphism rs4648889 in a putative enhancer upstream of the RUNX3 promoter associated with susceptibility to ankylosing spondylitis (AS). Methods Using nuclear extracts from Jurkat cells and primary human CD8+ T cells,...

Full description

Bibliographic Details
Main Authors: Vecellio, M, Chen, L, Cohen, CJ, Cortes, A, Li, Y, Bonham, S, Selmi, C, Brown, MA, Fischer, R, Knight, JC, Wordsworth, BP
Format: Journal article
Language:English
Published: Wiley 2021
_version_ 1826307853686669312
author Vecellio, M
Chen, L
Cohen, CJ
Cortes, A
Li, Y
Bonham, S
Selmi, C
Brown, MA
Fischer, R
Knight, JC
Wordsworth, BP
author_facet Vecellio, M
Chen, L
Cohen, CJ
Cortes, A
Li, Y
Bonham, S
Selmi, C
Brown, MA
Fischer, R
Knight, JC
Wordsworth, BP
author_sort Vecellio, M
collection OXFORD
description Objective To investigate the functional consequences of the single-nucleotide polymorphism rs4648889 in a putative enhancer upstream of the RUNX3 promoter associated with susceptibility to ankylosing spondylitis (AS). Methods Using nuclear extracts from Jurkat cells and primary human CD8+ T cells, the effects of rs4648889 on allele-specific transcription factor (TF) binding were investigated by DNA pull-down assay and quantitative mass spectrometry (qMS), with validation by electrophoretic mobility shift assay (EMSA), Western blotting of the pulled-down eluates, and chromatin immunoprecipitation (ChIP)–quantitative polymerase chain reaction (qPCR) analysis. Further functional effects were tested by small interfering RNA knockdown of the gene for interferon regulatory factor 5 (IRF5), followed by reverse transcription–qPCR (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA) to measure the levels of IFNγ messenger RNA (mRNA) and protein, respectively. Results In nuclear extracts from CD8+ T cells, results of qMS showed that relative TF binding to the AS-risk A allele of rs4648889 was increased 3.7-fold (P < 0.03) for Ikaros family zinc-finger protein 3 (IKZF3; Aiolos) and components of the NuRD complex, including chromodomain helicase DNA binding protein 4 (CHD4) (3.6-fold increase; P < 0.05) and retinoblastoma binding protein 4 (RBBP4) (4.1-fold increase; P < 0.03). In contrast, IRF5 bound significantly more to the AS-protective G allele compared to the AS-risk A allele (fold change 8.2; P = 0.003). Validation with Western blotting, EMSA, and ChIP-qPCR confirmed the differential allelic binding of IKZF3, CHD4, RBBP4, and IRF5. Silencing of IRF5 in CD8+ T cells increased the levels of IFNγ mRNA as measured by RT-qPCR (P = 0.03) and IFNγ protein as measured by ELISA (P = 0.02). Conclusion These findings suggest that the association of rs4648889 with AS reflects allele-specific binding of this enhancer-like region to certain TFs, including IRF5, IKZF3, and members of the NuRD complex. IRF5 may have crucial influences on the functions of CD8+ lymphocytes, a finding that could reveal new therapeutic targets for the management of AS.
first_indexed 2024-03-07T07:09:17Z
format Journal article
id oxford-uuid:7a11dd7c-1926-4b9e-b424-549e38be6deb
institution University of Oxford
language English
last_indexed 2024-03-07T07:09:17Z
publishDate 2021
publisher Wiley
record_format dspace
spelling oxford-uuid:7a11dd7c-1926-4b9e-b424-549e38be6deb2022-06-07T13:19:18ZFunctional genomic analysis of a RUNX3 polymorphism associated with ankylosing spondylitisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7a11dd7c-1926-4b9e-b424-549e38be6debEnglishSymplectic ElementsWiley2021Vecellio, MChen, LCohen, CJCortes, ALi, YBonham, SSelmi, CBrown, MAFischer, RKnight, JCWordsworth, BPObjective To investigate the functional consequences of the single-nucleotide polymorphism rs4648889 in a putative enhancer upstream of the RUNX3 promoter associated with susceptibility to ankylosing spondylitis (AS). Methods Using nuclear extracts from Jurkat cells and primary human CD8+ T cells, the effects of rs4648889 on allele-specific transcription factor (TF) binding were investigated by DNA pull-down assay and quantitative mass spectrometry (qMS), with validation by electrophoretic mobility shift assay (EMSA), Western blotting of the pulled-down eluates, and chromatin immunoprecipitation (ChIP)–quantitative polymerase chain reaction (qPCR) analysis. Further functional effects were tested by small interfering RNA knockdown of the gene for interferon regulatory factor 5 (IRF5), followed by reverse transcription–qPCR (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA) to measure the levels of IFNγ messenger RNA (mRNA) and protein, respectively. Results In nuclear extracts from CD8+ T cells, results of qMS showed that relative TF binding to the AS-risk A allele of rs4648889 was increased 3.7-fold (P < 0.03) for Ikaros family zinc-finger protein 3 (IKZF3; Aiolos) and components of the NuRD complex, including chromodomain helicase DNA binding protein 4 (CHD4) (3.6-fold increase; P < 0.05) and retinoblastoma binding protein 4 (RBBP4) (4.1-fold increase; P < 0.03). In contrast, IRF5 bound significantly more to the AS-protective G allele compared to the AS-risk A allele (fold change 8.2; P = 0.003). Validation with Western blotting, EMSA, and ChIP-qPCR confirmed the differential allelic binding of IKZF3, CHD4, RBBP4, and IRF5. Silencing of IRF5 in CD8+ T cells increased the levels of IFNγ mRNA as measured by RT-qPCR (P = 0.03) and IFNγ protein as measured by ELISA (P = 0.02). Conclusion These findings suggest that the association of rs4648889 with AS reflects allele-specific binding of this enhancer-like region to certain TFs, including IRF5, IKZF3, and members of the NuRD complex. IRF5 may have crucial influences on the functions of CD8+ lymphocytes, a finding that could reveal new therapeutic targets for the management of AS.
spellingShingle Vecellio, M
Chen, L
Cohen, CJ
Cortes, A
Li, Y
Bonham, S
Selmi, C
Brown, MA
Fischer, R
Knight, JC
Wordsworth, BP
Functional genomic analysis of a RUNX3 polymorphism associated with ankylosing spondylitis
title Functional genomic analysis of a RUNX3 polymorphism associated with ankylosing spondylitis
title_full Functional genomic analysis of a RUNX3 polymorphism associated with ankylosing spondylitis
title_fullStr Functional genomic analysis of a RUNX3 polymorphism associated with ankylosing spondylitis
title_full_unstemmed Functional genomic analysis of a RUNX3 polymorphism associated with ankylosing spondylitis
title_short Functional genomic analysis of a RUNX3 polymorphism associated with ankylosing spondylitis
title_sort functional genomic analysis of a runx3 polymorphism associated with ankylosing spondylitis
work_keys_str_mv AT vecelliom functionalgenomicanalysisofarunx3polymorphismassociatedwithankylosingspondylitis
AT chenl functionalgenomicanalysisofarunx3polymorphismassociatedwithankylosingspondylitis
AT cohencj functionalgenomicanalysisofarunx3polymorphismassociatedwithankylosingspondylitis
AT cortesa functionalgenomicanalysisofarunx3polymorphismassociatedwithankylosingspondylitis
AT liy functionalgenomicanalysisofarunx3polymorphismassociatedwithankylosingspondylitis
AT bonhams functionalgenomicanalysisofarunx3polymorphismassociatedwithankylosingspondylitis
AT selmic functionalgenomicanalysisofarunx3polymorphismassociatedwithankylosingspondylitis
AT brownma functionalgenomicanalysisofarunx3polymorphismassociatedwithankylosingspondylitis
AT fischerr functionalgenomicanalysisofarunx3polymorphismassociatedwithankylosingspondylitis
AT knightjc functionalgenomicanalysisofarunx3polymorphismassociatedwithankylosingspondylitis
AT wordsworthbp functionalgenomicanalysisofarunx3polymorphismassociatedwithankylosingspondylitis